| # | Drug | Count |
|---|---|---|
| 0 | CABOTEGRAVIR AND RILPIVIRINE | 2 |
| 1 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 |
| 2 | 0XYGEN | 1 |
| 3 | ACYCLOVIR | 1 |
| 4 | AMITRIPTYLINE HYDROCHLORIDE | 1 |
| 5 | CALCIUM | 1 |
| 6 | CEFPODOXIME PROXETIL | 1 |
| 7 | CERLIPONASE ALFA | 1 |
| 8 | CETIIRIZINE | 1 |
| 9 | CETIRIZINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0064 |
| 1 | CERLIPONASE ALFA | 1 | 0.0019 |
| 2 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 3 | CABOTEGRAVIR AND RILPIVIRINE | 2 | 0.0003 |
| 4 | KETAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | KETOPROFEN | 1 | 0.0001 |
| 6 | TEDUGLUTIDE | 1 | 0.0001 |
| 7 | AMITRIPTYLINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | NALTREXONE | 1 | 0.0000 |
| 9 | CETIIRIZINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 1 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Antiarrhythmic [EPC] | 1 | 0.0000 |